Metabolon Partners with China Kadoorie Biobank to Advance Precision Health
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic…
Athira Pharma Announces Reverse Stock Split
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira”…
Young voices drive SCO innovation and culture
BEIJING, Sept. 9, 2025 /PRNewswire/ -- A news report from China Daily:…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025 18:00 ET | Source: Rackspace US, Inc. SAN ANTONIO,…
Customers Bancorp, Inc. Announces Pricing of Voting Common Stock Offering
WEST READING, Pa.--(BUSINESS WIRE)--$CUBI #Banking--Customers Bancorp, Inc. (NYSE: CUBI) (“Customers” or the…
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…
/C O R R E C T I O N — Public Interest Registry/
Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor…
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…